Comparisons of serum levels of insulin-like growth factor I, II, and binding protein 3, transforming growth factor β-1, soluble fas ligand and superoxide dismutase activity in stomach cancer cases and their controls. The gene discussed is FASLG; the disease is gastric cancer.